Your email has been successfully added to our mailing list.

×
-0.0185619799445274 -0.0185619799445274 -0.0288030723277149 -0.0288030723277149 -0.0185619799445274 -0.0014934926392148 -0.00554725837422657 0.000640068273949269
Stock impact report

Amarin Receives National Reimbursement for VAZKEPA® in Italy

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share (AMRN) 
Last amarin corporation plc - american depositary shares, each representing one ordinary share earnings: 4/30 05:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.amarincorp.com/investors
Company Research Source: GlobeNewswire
-- Italian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Cardiovascular Risk in Eligible High-Risk Patients1 -- -- Italy is the Third EU5 Market to Grant National Reimbursement; Ninth National Reimbursement for VAZKEPA® Overall in Europe -- -- European Progress Has Advanced Patient Access: Countries That Have Provided Access to VAZKEPA Now Account for More Than 50% of the Total Established Cardiovascular Disease (eCVD) Population in Western Europe -- -- Italy Approval Further Validates the Progress Made by the Company Following Execution of a New Strategy Implemented in 2023 -- DUBLIN and BRIDGEWATER, N.J., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced that Italy’s National Health Service (NHS) approved VAZKEPA® for national reimbursement to reduce cardiovascular risk in eligible high-risk patients, as published in the Official Journal of the Italian Republic (i.e. Gazzetta Ufficiale della Re Show less Read more
Impact Snapshot
Event Time:
AMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AMRN alerts
Opt-in for
AMRN alerts

from News Quantified
Opt-in for
AMRN alerts

from News Quantified